Somerset Indus Capital Partners
Somerset Indus Capital Partners, established in 2014, is a Mumbai-based growth equity investment firm focusing on the Indian healthcare sector. The firm specializes in providing growth capital, typically investing between $5 million to $25 million, to small and mid-sized companies operating in healthcare services and products. Its investment focus includes pharmaceuticals, medical devices, diagnostics, preventive care & wellness, healthcare financing, digital health, and healthcare delivery models. The firm seeks controlling or influential minority investments in growth-oriented companies, aiming to drive value through strategic partnerships and operational improvements. Somerset Indus Capital Partners is led by Avinash Kenkare, a seasoned private equity professional, and Mayur Sirdesai, an experienced healthcare industry veteran.
Globela Pharma
Private Equity Round in 2021
Globela Pharma is a pharmaceutical formulation manufacturing company that provides services to clients in various countries, including Bolivia, Costa Rica, Panama, Venezuela, Chile, Nigeria, Myanmar, Kenya, the Philippines, Sri Lanka, Ghana, Vietnam, and Ivory Coast. The company specializes in producing a range of medications, including general pharmacology products, oncology treatments, immunosuppressants, and cephalosporins. By adhering to global standards, Globela Pharma aims to deliver high-quality pharmaceutical products to meet the needs of its diverse clientele.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.